Coleman J W, Yeung J H, Tingle M D, Park B K
J Immunol Methods. 1986 Apr 3;88(1):37-44. doi: 10.1016/0022-1759(86)90049-9.
Certain hypersensitivity reactions to drugs are thought to depend on coupling of reactive species (the drug itself or a metabolite) to macromolecules, leading to the formation of hapten-carrier conjugates. In assays for the detection of antibodies directed against such reactive species the drug or metabolite must be used in conjugated rather than free form. We describe ELISAs for the detection of anti-dinitrophenyl (DNP), anti-captopril (CP) and anti-sulphanilamidobenzoic acid (SABA) antibodies, in which the wells of microtitre plates are coated with hapten conjugated to protein. We define coating conditions and the following 3 criteria for identification of anti-hapten activity: Immunoglobulin in the test sample binds to the immobilised hapten-protein conjugate, but not to the immobilised protein alone. Binding is inhibited by preincubation of the test sample with protein conjugates incorporating the test hapten, but not by preincubation with the same unconjugated proteins, nor protein conjugates incorporating haptenic groups unrelated to the test hapten. The inhibitory hapten-protein conjugates are shown to be inactive in unrelated antigen-antibody interactions. Binding is blocked by preincubation of the test sample with low molecular weight chemical derivatives of the reactive hapten. The inhibitory derivatives must be shown to be inactive in unrelated antigen-antibody interactions. On the basis of these criteria, IgG anti-DNP and IgG anti-CP were detected in the sera of immunized rabbits. The IgG anti-DNP antibody recognised protein-conjugated DNP, DNP-lysine, N-acetyl-DNP-lysine and DNP-S-glutathione, whereas the IgG anti-CP antibody recognised CP-S-S-protein and CP-S-S-CP. By the same criteria IgG anti-SABA was detected in the sera of immunized mice. The antibody recognised free and protein-conjugated SABA, but not free sulphanilamide.
某些药物超敏反应被认为取决于反应性物质(药物本身或代谢物)与大分子的偶联,导致半抗原 - 载体缀合物的形成。在检测针对此类反应性物质的抗体的试验中,必须使用缀合形式而非游离形式的药物或代谢物。我们描述了用于检测抗二硝基苯基(DNP)、抗卡托普利(CP)和抗磺胺氨基苯甲酸(SABA)抗体的酶联免疫吸附测定(ELISA),其中微量滴定板的孔用与蛋白质偶联的半抗原包被。我们定义了包被条件以及用于鉴定抗半抗原活性的以下3条标准:测试样品中的免疫球蛋白与固定化的半抗原 - 蛋白质缀合物结合,但不与单独的固定化蛋白质结合。通过将测试样品与掺入测试半抗原的蛋白质缀合物预孵育可抑制结合,但与相同的未缀合蛋白质预孵育或与掺入与测试半抗原无关的半抗原基团的蛋白质缀合物预孵育则不能抑制结合。显示抑制性半抗原 - 蛋白质缀合物在无关的抗原 - 抗体相互作用中无活性。通过将测试样品与反应性半抗原的低分子量化学衍生物预孵育可阻断结合。必须证明抑制性衍生物在无关的抗原 - 抗体相互作用中无活性。基于这些标准,在免疫兔的血清中检测到了IgG抗DNP和IgG抗CP。IgG抗DNP抗体识别蛋白质偶联的DNP、DNP - 赖氨酸、N - 乙酰 - DNP - 赖氨酸和DNP - S - 谷胱甘肽,而IgG抗CP抗体识别CP - S - S - 蛋白质和CP - S - S - CP。按照相同标准,在免疫小鼠的血清中检测到了IgG抗SABA。该抗体识别游离和蛋白质偶联的SABA,但不识别游离磺胺。